Your Complete Guide to Global Clinical Research and GCP Compliance
Documenting Performance Management & SLAs for Audits, Health Authority Queries and Due Diligence Documenting Performance Management & SLAs for Audits, Health Authority Queries and Due Diligence Understanding the Importance of Performance Management in Clinical Trials In the realm of clinical trials, especially in regulatory environments governed by agencies like the FDA, EMA, and MHRA, the…
Digital Tools and Automation That Transform Performance Management & SLAs in Clinical Development Digital Tools and Automation That Transform Performance Management & SLAs in Clinical Development In today’s rapidly evolving clinical research landscape, the integration of digital tools and automation plays a crucial role in enhancing the performance of clinical trials. The adoption of clinical…
Case Studies: Performance Management & SLAs That Rescued High-Risk Studies and Vendors Case Studies: Performance Management & SLAs That Rescued High-Risk Studies and Vendors In the highly regulated environment of clinical trials, maintaining performance management and Service Level Agreements (SLAs) is crucial, particularly in high-risk studies. This comprehensive tutorial guides clinical operations, regulatory affairs, and…
Read More “Case Studies: Performance Management & SLAs That Rescued High-Risk Studies and Vendors” »
Integrating Performance Management & SLAs With QMS, Risk Registers and Governance Committees Performance management and Service Level Agreements (SLAs) are vital components of clinical trial operations, particularly in the context of CDMS clinical trials. The successful execution of clinical trials requires robust mechanisms that ensure compliance with regulatory standards and operational excellence. This tutorial provides…
Future-Proofing Performance Management & SLAs for AI, Real-World Data and Platform Trials Future-Proofing Performance Management & SLAs for AI, Real-World Data and Platform Trials In the rapidly evolving landscape of clinical trials, particularly in areas such as clinical trials for small cell lung cancer, there is an increasing emphasis on the integration of advanced technologies,…
Aligning Performance Management & SLAs With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Performance Management & SLAs With ICH E6(R3), GCP and Quality-by-Design Principles Introduction: Importance of Performance Management in Clinical Trials In the rapidly evolving landscape of clinical research, aligning performance management frameworks with regulatory standards such as ICH E6(R3) and Good Clinical Practice…
Performance Management & SLAs Checklists for Clinical Operations and Vendor Governance Teams Effective performance management and stringent adherence to Service Level Agreements (SLAs) are paramount in the realm of clinical trials. This is particularly vital in platform clinical trial settings, where multiple stakeholders, including Contract Research Organizations (CROs) and site management teams, are involved in…
Common Pitfalls in Performance Management & SLAs—and How to Avoid Regulatory Findings Common Pitfalls in Performance Management & SLAs—and How to Avoid Regulatory Findings In the context of clinical trials, performance management and service level agreements (SLAs) are pivotal in ensuring compliance with regulatory standards while promoting operational effectiveness. Effective vendor oversight and engagement with…
Read More “Common Pitfalls in Performance Management & SLAs—and How to Avoid Regulatory Findings” »
Using KPIs and SLAs to Optimize Performance Management & SLAs Across CROs and Service Providers In the clinical trial landscape, the significance of effective vendor oversight cannot be overstated. Key Performance Indicators (KPIs) and Service Level Agreements (SLAs) form the backbone of performance management, especially when dealing with Contract Research Organizations (CROs) and service providers….
Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials As clinical trials evolve, particularly in the context of decentralized and hybrid models, managing performance through Service Level Agreements (SLAs) becomes imperative. The increasing use of digital technologies and data-heavy processes necessitates rigorous…
Read More “Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials” »